|
by Wells, Charlotte, Loshak, Hannah
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Wells, Charlotte, Loshak, Hannah
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Wells, Charlotte, Dulong, Camille, McCormack, Suzanne
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Wells, Charlotte, Dulong, Camille, McCormack, Suzanne
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Yeung, Shirley S. T., Farrah, Kelly
Published 2019
“... localization of non-palpable breast lesions, as well as the guidelines for its use...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Sutton, Desirée, Spry, Carolyn
Published 2019
“... of one dose of doxycycline for the prevention of Lyme disease in patients with tick attachment as well...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Yeung, Shirley S. T., Farrah, Kelly
Published 2019
“... localization of non-palpable breast lesions, as well as the guidelines for its use...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Sutton, Desirée, Spry, Carolyn
Published 2019
“... of one dose of doxycycline for the prevention of Lyme disease in patients with tick attachment as well...”Published 2019
Canadian Agency for Drugs and Technologies in Health